Search research articles
Contact Us
Filters
Showing results (81-90 of 129) with videos related to
Page
of 13
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
December 25, 2004
Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies
S K Pathak, R A Sharma, W P Steward, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis
A G Kamthan, M J Lind, N Thatcher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 20, 2005
Concomitant chemoradiotherapy for muscle-invasive bladder cancer: the way forward for bladder preservation?
B T Sherwood, G D D Jones, J K Mellon, et al.
Cancer Treatment Reports
|
September 1, 1987
Phase I clinical trial of methylene dimethane sulfonate
D B Smith, B W Fox, N Thatcher, et al.
British Journal of Cancer
|
April 26, 2000
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
K J O'Byrne, M I Koukourakis, A Giatromanolaki, et al.
Investigational New Drugs
|
March 1, 2006
Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouse
S Sale, R G Tunstall, K C Ruparelia, et al.
British Journal of Cancer
|
February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma
R A Cowan, M Jones, M Harris, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2000
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study
A L Thomas, G Cox, R A Sharma, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma Group
W P Steward, J Verweij, R Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
W P Steward, J Verweij, R Somers, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 129) with videos related to
Sort By:
Page
of 13
European Journal of Cancer (Oxford, England : 1990)
|
December 25, 2004
Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies
S K Pathak, R A Sharma, W P Steward, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1990
Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosis
A G Kamthan, M J Lind, N Thatcher, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 20, 2005
Concomitant chemoradiotherapy for muscle-invasive bladder cancer: the way forward for bladder preservation?
B T Sherwood, G D D Jones, J K Mellon, et al.
Cancer Treatment Reports
|
September 1, 1987
Phase I clinical trial of methylene dimethane sulfonate
D B Smith, B W Fox, N Thatcher, et al.
British Journal of Cancer
|
April 26, 2000
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer
K J O'Byrne, M I Koukourakis, A Giatromanolaki, et al.
Investigational New Drugs
|
March 1, 2006
Effects of the potential chemopreventive agent DMU-135 on adenoma development in the ApcMin+ mouse
S Sale, R G Tunstall, K C Ruparelia, et al.
British Journal of Cancer
|
February 1, 1989
Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma
R A Cowan, M Jones, M Harris, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 30, 2000
Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study
A L Thomas, G Cox, R A Sharma, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
The use of recombinant human granulocyte-macrophage colony-stimulating factor with combination chemotherapy in the treatment of advanced adult soft-tissue sarcomas: early results from the EORTC Soft-Tissue and Bone Sarcoma Group
W P Steward, J Verweij, R Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
W P Steward, J Verweij, R Somers, et al.
Page
of 13